Risk prediction in acute coronary syndrome depending on the types of myocard revascularization

Authors

  • R. V. Denina State Higher Educational Establishment “Ivano-Frankivsk National Medical University”, Ukraine,

DOI:

https://doi.org/10.14739/2310-1210.2016.6.85485

Keywords:

Prognosis, Myocardial Infarction, Risk, Revascularization, NT–proBNP, GRACE

Abstract

Risk of complications in patients with acute coronary syndrome determination has received much attention and offered a variety of options for scales in the last years. GRACE scale is the most informative method to assess the risk of death during hospitalization period and during the next 6 months at present. Some studies recommend to complement GRACE scale with detection of the N-terminal prohormone brain natriuretic peptide (NT-proBNP) blood levels.

The purpose of the study was to assess risk factors by GRACE scale and activity in serum levels of NT–proBNP in myocardial infarction depending on the types of coronary arteries revascularization.

Materials and Methods. The study involved 80 patients with acute myocardial infarction with heart failure; the average age of patients was (61.16±5.79) years, 52 (65 %) men. The patients were divided into 4 groups. Group I included patients who were prescribed thrombolytic therapy (n=10); group II patients underwent percutaneous coronary intervention (PCI) with stenting of the infarction–depending vessels (n=35); group III involved patients (n=23) who were administered both methods of treatment. Group IV included 12 individuals who were administered conservative treatment.

Results. The research showed that the lowest levels of NT–proBNP were observed on the 7th day in patients who have been administered percutaneous coronary intervention (PCI) with stenting of the infarction–depending vessels (254.1±11.3 fmol/ml, p<0.05).  The risk of adverse events evaluated by the GRACE scale in patients with MI after performed PCI with stenting of the infarction–depending vessels and thrombolytic therapy is lower (12.2±1.35 %) than in patients who were administered thrombolytic therapy (14.23±0.58 %) and those with conservative treatment (15.63±0.89 %).

Conclusion. The risk of death by GRACE scale in patients with myocardial infarction after performed PCI with stenting of the infarction–depending vessels and thrombolytic therapy is lower than in patients without coronary intervention.

References

Florira, M. et al. (2009) GRACE risk score in patients with acute coronary syndrome: the practical utility at hospital admission. Acta Cardiologia, 64(1), 133–134.

Park, K. L., Goldberg, R. J., Anderson, F. A., López-Sendón, J., Montalescot, G., Brieger, D. et al. (2014) Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE). Am J Med., 127(6), 503–511. doi: 10.1016/j.amjmed.2014.02.009.

Scirica, B. M., Cannon, C. P., Antman, E. M., Murphy, S. A., Morrow, D. A., Sabatine, M. S. et al. (2002) Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry. Am J Cardiol., 90, 303–305.

Park, K. L., Budaj, A., Goldberg, R. J., Anderson, F. A. Jr, Agnelli, G., Kennelly, B. M. et al. (2012) Risk-prediction model for ischemic stroke in patients hospitalized with an acute coronary syndrome (from the Global Registry of Acute Coronary Events). Am. J.Cardiol., 111950, 628–635.

Maisel, A., Xue, Y., Greene, S. J., Pang, P. S., Januzzi, J. L., Piña, I. L., et al. (2015) The potential role of natriuretic peptide-guided management for patients hospitalized for heart failure. J Card Fail., 21, 233–239. doi: 10.1016/j.cardfail.2014.11.009.

De Lemos, J. A. (2001) The prognostic value of BNP in patients with ACS. N. Engl. J. Med., 4(345), 14, 1014–1021.

Schnabel, R., Lubos, E., Rupprecht, H. J., Espinola-Klein, C., Bickel, C., Karl, J. et al. (2006) BNP and the risk of cardiovascular events and death in patients with stable angina: results from the Athero Gene study. J. Am. Coll. Cardiol., 47, 552–558. doi: 10.1016/j.jacc.2005.09.039.

Zdravkovic, V., Mladenovic, V., Colic, M., Bankovic, D., Lazic, Z., Petrovic, M. et al. (2013) NT-proBNP for prognostic and diagnostic evaluation in patients with acute coronary syndromes. Kardiologia Polska, 71(5), 472–479. doi: 10.5603/KP.2013.0093.

Granger, C. B., Goldberg, R. J., Dabbous, O., Pieper, K. S., Eagle, K. A., Cannon, C. P., et al. (2003) Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med., 163, 2345–2353.

Sun, Y. H., Wang, G. L., Fu, Y. Y., Xue, C., & Hu, D. Y. (2009) Prognostic value of point of care B-type natriuretic peptide testing and GRACE score in patients with acute coronary syndrome. Zhonghua Xin Xue Guan Bing Za Zhi., 37(8), 716–720.

Downloads

How to Cite

1.
Denina RV. Risk prediction in acute coronary syndrome depending on the types of myocard revascularization. Zaporozhye medical journal [Internet]. 2016Dec.8 [cited 2024Apr.19];18(6). Available from: http://zmj.zsmu.edu.ua/article/view/85485

Issue

Section

Original research